BSE Live
Dec 10, 09:09Prev. Close
316.00
Open Price
324.95
Bid Price (Qty.)
308.00 (5)
Offer Price (Qty.)
324.95 (6)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Trident Texofab (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.94 | 3.19 | 1.88 | 9.92 | 0.18 | |
| Diluted EPS (Rs.) | 0.94 | 3.19 | 2.32 | 9.92 | 0.18 | |
| Cash EPS (Rs.) | 4.77 | 3.95 | 2.19 | 13.84 | 5.84 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 28.59 | 27.02 | 20.68 | 114.30 | 104.36 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 28.59 | 27.02 | 20.68 | 114.30 | 104.36 | |
| Dividend / Share(Rs.) | 0.00 | 1.00 | 1.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 227.64 | 217.47 | 213.88 | 2,289.30 | 1,988.52 | |
| PBDIT/Share (Rs.) | 13.14 | 6.81 | 4.84 | 41.96 | 31.33 | |
| PBIT/Share (Rs.) | 10.61 | 6.05 | 4.52 | 38.03 | 27.26 | |
| PBT/Share (Rs.) | 3.83 | 4.23 | 2.59 | 17.47 | 2.81 | |
| Net Profit/Share (Rs.) | 2.25 | 3.19 | 1.88 | 9.92 | 1.77 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 5.77 | 3.13 | 2.26 | 1.83 | 1.57 | |
| PBIT Margin (%) | 4.66 | 2.78 | 2.11 | 1.66 | 1.37 | |
| PBT Margin (%) | 1.68 | 1.94 | 1.21 | 0.76 | 0.14 | |
| Net Profit Margin (%) | 0.98 | 1.46 | 0.87 | 0.43 | 0.08 | |
| Return on Networth / Equity (%) | 7.88 | 11.80 | 9.07 | 8.68 | 1.69 | |
| Return on Capital Employed (%) | 16.05 | 11.92 | 14.50 | 3.65 | 1.47 | |
| Return on Assets (%) | 1.61 | 2.70 | 1.66 | 1.34 | 0.15 | |
| Total Debt/Equity (X) | 1.78 | 1.19 | 0.50 | 1.37 | 0.86 | |
| Asset Turnover Ratio (%) | 163.38 | 184.71 | 190.18 | 310.19 | 173.69 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.37 | 1.35 | 1.24 | 1.43 | 1.06 | |
| Quick Ratio (X) | 1.02 | 1.20 | 1.08 | 1.29 | 0.79 | |
| Inventory Turnover Ratio (X) | 9.00 | 22.14 | 16.86 | 32.92 | 7.03 | |
| Dividend Payout Ratio (NP) (%) | 45.49 | 31.35 | 42.84 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 21.46 | 25.32 | 36.68 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 54.51 | 68.65 | 57.16 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 78.54 | 74.68 | 63.32 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 61.88 | 51.86 | 54.26 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.68 | 0.60 | 0.63 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 11.79 | 19.07 | 28.08 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.46 | 0.45 | 0.59 | 0.00 | 0.00 | |
| Retention Ratios (%) | 54.50 | 68.64 | 57.15 | 0.00 | 0.00 | |
| Price/BV (X) | 3.62 | 3.63 | 6.09 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.46 | 0.45 | 0.59 | 0.00 | 0.00 | |
| Earnings Yield | 0.02 | 0.03 | 0.01 | 0.00 | 0.00 |
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
05.04.2017
30.03.2017
29.03.2017
28.03.2017